Liminal Biosciences (NASDAQ:LMNL) will report on Q4 2022.
TuSimple Announces Restructuring With Focus On Investing In R&D To Advance Autonomous Trucking Technology
TuSimple (Nasdaq: TSP), a global autonomous driving technology company, announced a restructuring plan designed to set the Company on the course to long-term success as a leader in the autonomous trucking